School of Medicine

Showing 1 of 1 Results

  • Fabio Iwamoto, MD

    Fabio Iwamoto, MD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and of Neurosurgery (Adult Neurosurgery)

    BioDr. Fabio Iwamoto is a board-certified, fellowship-trained neuro-oncologist at Stanford Health Care. He is also a professor in the Department of Neurology & Neurological Sciences, Division of Neuro-Oncology, and a professor of neurosurgery in the Department of Neurosurgery, Division of Neurosurgical Oncology at Stanford University School of Medicine.

    Dr. Iwamoto cares for brain and spinal cord tumors, guiding patients from diagnosis through treatment and follow-up. He specializes in managing cancer that has spread to the brain or spinal cord, working with multiple specialists to develop individualized treatment plans. He also has expertise treating tumors called gliomas, including glioblastomas. Throughout the patient journey, Dr. Iwamoto addresses cancer-related complications, such as cancer therapy side effects, numbness, and memory problems. He strives to deliver the highest level of compassionate, patient-centered care, supporting patients and families through complex decisions and challenging moments.

    Dr. Iwamoto’s research focuses on developing and evaluating innovative treatments for brain tumors, particularly gliomas and glioblastomas. He studies immunotherapies, targeted therapies, and novel therapy combinations to improve tumor treatment. He leads several national and international clinical trials with the goal of bringing promising discoveries from the laboratory to patients.

    Dr. Iwamoto has authored many publications in leading journals, including Nature Cancer, Nature Medicine, Neuro-Oncology, and the Journal of Clinical Oncology. He has published several book chapters on key topics in neuro-oncology, including emerging glioma treatments and the diagnosis and management of central nervous system tumors. He has also shared his expertise and research findings around the world at meetings of the American Society of Clinical Oncology, American Association for Cancer Research, and international neuro-oncology forums.